Lynda Charters

Articles

AAO 2020: Fingolimod for MS offers disease control with no development of uveitis

November 15, 2020

Bradley Smith, MD, presents at AAO 2020 on how fingolimod 0.5 mg, a first-line treatment for multiple sclerosis, may reduce both the number of relapses and disease progression in patients with relapsing-remitting MS as well as the incidence of uveitis.

AAO 2020: Headache paired with visual loss may require honing of detective skills

November 14, 2020

During AAO 2020, Kathleeen B. Digre, MD, details how a headache in conjunction with visual loss is a scenario that requires an in-depth examination, including evaluation of the visual fields, pupils, and fundus to gather clues to the diagnosis.

AAO 2020: Autologous retinal transplant for larger macular holes gaining traction

November 14, 2020

Tamer Mahmoud, MD, PhD, discusses autologous retinal transplant (ART) for macular holes, a procedure he developed, which is providing anatomic hole closure in the vast majority of cases as well as increases in visual acuity.